Aerodigestive Center, Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, MA.
Institutional Centers for Clinical and Translational Research, Boston Children's Hospital, Boston, MA.
J Pediatr. 2018 Oct;201:141-146. doi: 10.1016/j.jpeds.2018.05.030. Epub 2018 Jun 28.
To determine if any presenting symptoms are associated with aspiration risk, and to evaluate the reliability of clinical feeding evaluation (CFE) in diagnosing aspiration compared with videofluoroscopic swallow study (VFSS).
We retrospectively reviewed records of children under 2 years of age who had evaluation for oropharyngeal dysphagia by CFE and VFSS at Boston Children's Hospital and compared presenting symptoms, symptom timing, and CFE and VFSS results. We investigated the relationship between symptom presence and aspiration using the Fisher exact test and stepwise logistic regression with adjustment for comorbidities. CFE and VFSS results were compared using the McNemar test. Intervals from CFE to VFSS were compared using the Student t test.
A total of 412 subjects with mean (±SD) age 8.9 ± 6.9 months were evaluated. No symptom, including timing relative to meals, predicted aspiration on VFSS. This lack of association between symptoms and VFSS results persisted even in the adjusted multivariate model. The sensitivity of CFE for predicting aspiration by VFSS was 44%. Patients with a reassuring CFE waited 28.2 ± 8.5 days longer for confirmatory VFSS compared with those with a concerning CFE (P < .05).
Presenting symptoms are varied in patients with aspiration and cannot be relied upon to determine which patients have aspiration on VFSS. The CFE does not have the sensitivity to consistently diagnose aspiration so a VFSS should be performed in persistently symptomatic patients.
确定是否存在任何表现症状与吸入风险相关,并评估临床喂养评估(CFE)在诊断吸入方面与荧光透视吞咽研究(VFSS)相比的可靠性。
我们回顾性地审查了在波士顿儿童医院接受 CFE 和 VFSS 评估的 2 岁以下儿童的病历,并比较了表现症状、症状出现时间以及 CFE 和 VFSS 结果。我们使用 Fisher 精确检验和逐步逻辑回归(考虑共病因素调整)调查了症状存在与吸入之间的关系。使用 McNemar 检验比较 CFE 和 VFSS 结果。使用学生 t 检验比较 CFE 到 VFSS 的时间间隔。
共 412 名平均(±SD)年龄为 8.9±6.9 个月的患者接受了评估。没有任何症状,包括与进餐时间的关系,能预测 VFSS 上的吸入。即使在调整后的多变量模型中,症状与 VFSS 结果之间也没有关联。CFE 预测 VFSS 吸入的敏感性为 44%。具有令人安心的 CFE 的患者比具有令人担忧的 CFE 的患者等待确认性 VFSS 的时间长 28.2±8.5 天(P<.05)。
存在吸入的患者表现症状各不相同,不能依靠这些症状来确定哪些患者在 VFSS 上存在吸入。CFE 没有足够的敏感性来一致诊断吸入,因此应在持续出现症状的患者中进行 VFSS。